Chronology of erectile function in patients with early functional erections following radical prostatectomy

Journal of Sexual Medicine

Volumn 7, Issue 2 PART 1, 2010, Pages 803-809

  Katz, Darren ^a   Bennett, Nelson E ^a   Stasi, Jason ^a   Eastham, James A ^a   Guillonneau, Bertrand D ^a   Scardino, Peter T ^a   Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Erectile function; IIEF; Prostate cancer; Radical prostatectomy

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; ARTICLE; DRUG UTILIZATION; ERECTILE DYSFUNCTION; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PENIS ERECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATECTOMY;

EID: 75649116487     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01516.x     Document Type: Article

References (36)

1. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: Likelihood, patterns of care, and outcomes. Cancer 2008, 112:307-14.
2. Underwood W, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005, 103:538-45.
3. Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 1993, 42:622-9.
4. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004, 172:2227-31.
5. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000, 283:354-60.
6. Menon M, Shrivastava A, Kaul S, Badani KK, Fumo M, Bhandari M, Peabody JO. Vattikuti Institute prostatectomy: Contemporary technique and analysis of results. Eur Urol 2007, 51:648-57. discussion 57-8
7. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy. J Urol 2009, 181:462-71.
8. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS. Factors affecting erectile function after radical retropubic prostatectomy: Results from 1,620 consecutive patients. BJU Int 2008, 101:833-6.
9. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000, 164:1929-34.
10. Dubbelman YD, Dohle GR, Schroder FH. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol 2006, 50:711-8. discussion 18-20
11. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000, 55:58-61.
12. Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S, Currie K, Ritvo P. Sexual dysfunction after radical prostatectomy: Prevalence, treatments, restricted use of treatments and distress. J Urol 2005, 174:2105-10.
13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49:822-30.
14. Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR. Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) investigators. Who is the average patient presenting with prostate cancer? Urology 2005, 66:76-82.
15. Eastham JA, Scardino PT, Kattan MW. Predicting an optimal outcome after radical prostatectomy: The trifecta nomogram. J Urol 2008, 179:2207-10. discussion 10-1
16. Crawford ED, Bennett CL, Stone NN, Knight SJ, DeAntoni E, Sharp L, Garnick MB, Porterfield HA. Comparison of perspectives on prostate cancer: Analyses of survey data. Urology 1997, 50:366-72.
17. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250-61.
18. Montorsi F, Padma-Nathan H, Glina S. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). Urology 2006, 68:26-37.
19. Althof SE, O'Leary MP, Cappelleri JC, Crowley AR, Tseng L-J, Collins S. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. J Urol 2006, 176:2132-7.
20. Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: How are they related? Br J Psychiatry 1988, 152:629-31.
21. O'Leary MP, Althof SE, Cappelleri JC, Crowley A, Sherman N, Duttagupta S. Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: A multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States. J Urol 2006, 175:1058-62.
22. Mulhall JP, Secin FP, Guillonneau B. Artery-sparing radical prostatectomy-myth or reality? J Urol 2008, 179:827-31.
23. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005, 173:1673-6.
24. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004, 171:771-4.
25. Son H, Park K, Kim S-W, Paick J-S. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004, 6:117-20.
26. Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008, 53:564-70.
27. Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK, Klein E, Zippe CD. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003, 62:110-5.
28. Gruenwald I, Shenfeld O, Chen J, Raviv G, Richter S, Cohen A, Vardi Y. Positive effect of counseling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol 2006, 50:134-40.
29. Bannowsky A, Schulze H, van der Horst C, Seif C, Braun PM, Junemann KP. Nocturnal tumescence: A parameter for postoperative erectile integrity after nerve sparing radical prostatectomy. J Urol 2006, 175:2214-7.
30. Noldus J, Michl U, Graefen M, Haese A, Hammerer P, Huland H. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol 2002, 42:118-24.
31. Saxena S, Caroni P. Mechanisms of axon degeneration: From development to disease. Prog Neurobiol 2007, 83:174-91.
32. Sanchez EC. Hyperbaric oxygenation in peripheral nerve repair and regeneration. Neurol Res 2007, 29:184-98.
33. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001, 4:1199-206.
34. Laser H, Conforti L, Morreale G, Mack TG, Heyer M, Haley JE, Wishart TM, Beirowski B, Walker SA, Haase G, Celik A, Adalbert R, Wagner D, Grumme D, Ribchester RR, Plomann M, Coleman MP. The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol Biol Cell 2006, 17:1075-84.
35. Coleman M. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 2005, 6:889-98.
36. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008, 179:S97-102.